Scholarly Index
Mirella Ezban
Novo Nordisk (Denmark); 4,640 total citations; 155 total publications; best world rank #161
Novo Nordisk (Denmark)
4,640Total citations
155Total publications
41H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Hemophilia Treatment and Research | Lifetime | 161 | DK 1 | 97.76 |
| Blood Coagulation and Thrombosis Mechanisms | Lifetime | 569 | DK 10 | 96.78 |
| Platelet Disorders and Treatments | Lifetime | 962 | DK 5 | 95.73 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | Lifetime | 812 | DK 7 | 94.75 |
| Hemostasis and retained surgical items | Lifetime | 493 | DK 11 | 84.40 |
| Hemophilia Treatment and Research | 2021-2025 | 590 | DK 5 | 73.76 |
| Blood Coagulation and Thrombosis Mechanisms | 2021-2025 | 771 | DK 7 | 68.57 |